Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy

L. Zhang, Z. Yu, P. Muranski, D. C. Palmer, N. P. Restifo, S. A. Rosenberg, R. A. Morgan

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences